NEXBOOK-L

NEXBOOK-L

NexBook L is designed to promote normal digestive function, making it a valuable option for individuals dealing with gastrointestinal issues.

THERAPY AREA: Gastroenterology/Phy
FORM: Tablet
PACKAGING: 10 x 10 Tablets

NexBook L, with Levosulpiride as its active ingredient, exerts its prokinetic effects by blocking dopamine receptors and activating serotonin receptors. This dual action leads to an increased release of acetylcholine, which, in turn, enhances GI peristalsis and raises lower esophageal sphincter pressure, ultimately preventing reflux of GI contents and promoting normal digestive function.

Mode Of Action:

Levosulpiride, found in NexBook L, operates through a dual mechanism of action, employing both dopamine receptor blockade and serotonin receptor agonism.

Dopamine (D2) Receptor Blockade: Levosulpiride blocks enteric dopamine (D2) receptors, both neuronal and muscular. By inhibiting dopamine receptors, Levosulpiride reduces the inhibitory signals in the gastrointestinal (GI) tract. Dopamine typically exerts inhibitory control, and by blocking its receptors, Levosulpiride enhances the release of acetylcholine.
Serotonin (5-HT4) Receptor Agonism: Levosulpiride acts as an agonist at serotonin (5-HT4) receptors. Stimulation of serotonin receptors, specifically the 5-HT4 subtype, further enhances the release of acetylcholine in the GI tract.

Indications:

Foe the treatment of

Dosage:

One capsule daily as prescribed by physician.

Instructions for usage:

  • As directed by physician

STORAGE:

Store at a temperature below 30°C in dry place. Keep out of reach of children.

Contraindications:

Pregnancy & lactation.
Known hypersensitivity to esomeprazole, any ingredient in the formulation, or other substituted benzimidazoles

FAQ’s:

NexBook L is generally prescribed for the treatment of specific conditions, and its long-term use should be discussed with a healthcare professional. It is not habit-forming, and the recommended dosage as per physician guidance ensures safe usage.

Yes, NexBook L is indicated for the treatment of Diabetic Gastroparesis, making it a valuable option for individuals dealing with gastrointestinal issues related to diabetes.

NexBook L is available in a tablet form and conveniently packaged in 10 x 10 tablets. This packaging ensures ease of use and portability, making it a practical choice for individuals incorporating it into their daily routine.

Composition

Each hard gelatin capsule contains
Esomeprazole Magnesium Trihydrate IP equivalent to Esomeprazole 40 mg (as enteric coated)
Levosulpiride IP 75 mg (as slow release)

Resources

No products in the cart.

test

Download

Kindly fill in your details. All fields mandatory.

    Download

    Kindly fill in your details. All fields mandatory.

      Raajesh Dhuria

      “To serve people with the highest quality healthcare solutions, and to do so through a brand they can always rely on for a healthier, happier lifestyle; because I believe there is no happiness without good health.” This is the simple, yet extraordinary vision of Mr Raajesh Dhuria, MD and CEO, a pharmaceutical leader with over three decades of experience not only in scaling up existing businesses in Multinational & Indian healthcare organisations but also creating new profitable ventures. A keen eye for identifying latest trends and driving teams with passion to create profitable brands and business is what distinguishes him from his peers. Having begun his career in the late 1980s, with Johnson & Johnson, Mr Dhuria up skilled himself quickly rose through his career to become a Sales Head in companies like Morepen labs & Cadila Pharmaceuticals in about a decade and a half. For many this would have been a big rise from a Medical representative to a sales head, but the hunger for doing things differently pushed him to do what very few people could achieve at that time- launch a pharmaceutical company. In 2003, Mr Dhuria launched Kinedex Healthcare Pvt. Ltd. He was responsible for the tremendous rise and success of the company over 15 years, including the popularity of the highly recommended brand for arthritis, Rosiflex. In 2019, the company was acquired by Eris pharmaceuticals, following which Mr Dhuria helped establish Novelty Healthshine and is now investing his time helping it reach even greater success. He sees the company as a listed one in another 5 years and at par with leading pharma companies. Mr Raajesh, is a self-motivated person and as any motivated person, he has a knack of developing talent by giving freedom of expression and ideas. He is highly receptive for innovating ideas and strategies to grow business and has a very strong appetite for novel ways to work. He has an extremely competent & committed team at work which is continuously working on delivering novel patient centric solutions & yes, a healthier and happier lifestyle.

      Raakesh Dhuria

      Raakesh is a very enthusiastic and energetic person with a perseverant nature. No wonder then, that he is an excellent leader guiding the field force at Novelty towards surpassing their goals year after year. Raakesh is one of the founder promoter Directors of Novelty HealthShine and has been associated with it since its inception. With his 30+ years of experience in Pharmaceutical selling he has risen from the ranks of a Medical representative to being a Director currently. Beginning his career at Lupin Laboratories, Raakesh has moved on to CFL as a frontline manager, followed by Morepen Laboratories. He embarked on his entrepreneurial journey beginning with Kinedex Healthcare and now at Novelty HealthShine. He has wide experience in selling brands of various therapeutic categories and supervising and motivating field force across the country. Raakesh is a Science Graduate with Masters in Business Administration and is passionate about keeping himself up-to-date with the latest in the field of medical and pharmaceutical research.

      Abhijit Singh

      Abhijit Singh is a seasoned Pharma leader who has front led Brand building, Business transformation & turnaround initiatives. With more than 2 decades of experience majorly in leadership positions at Zydus & Torrent - he is associated with popular brands with extensive work in Gastroenterology therapeutic area. A product innovator and a strategic thinker, he is constantly in pursuit of excellence in marketing and bringing about innovation to the customers. As an Executive Director at Novelty health shine, he is nurturing a multi-therapy product line with a focus on Nutrition. His role here is to bring innovation and carve a strategic charter to help the brands scale rapidly. Abhijit holds a Bachelor’s degree in Biochemistry and a Masters in Business Administration.

      Download Brochure

      Kindly fill in your details. All fields mandatory.